Education
About Us
Working with TipRanks
Follow Us
Solesence, Inc (SLSN)
:SLSN
SLSN Stock Chart & Stats
$3.88
--
Market closed
$3.88
--
Day’s Range― - ―
52-Week Range$1.34 - $16.56
Previous CloseN/A
VolumeN/A
Average Volume (3M)36.54K
Market Cap
$230.48M
Enterprise Value$338.66M
Total Cash (Recent Filing)$4.11M
Total Debt (Recent Filing)$10.71M
Price to Earnings (P/E)45.3
Beta1.18
Next Earnings
Nov 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding70,481,940
10 Day Avg. Volume15,968
30 Day Avg. Volume36,536
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.47
Enterprise Value/Revenue5.26
Enterprise Value/Gross Profit18.68
Enterprise Value/Ebitda46.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Solesence News
SLSN FAQ
What was Solesence, Inc’s price range in the past 12 months?
Solesence, Inc lowest stock price was $1.34 and its highest was $16.56 in the past 12 months.
What is Solesence, Inc’s market cap?
Solesence, Inc’s market cap is $230.48M.
When is Solesence, Inc’s upcoming earnings report date?
Solesence, Inc’s upcoming earnings report date is Nov 11, 2025 which is in 9 days.
How were Solesence, Inc’s earnings last quarter?
Solesence, Inc released its earnings results on Jul 31, 2025. The company reported $0.037 earnings per share for the quarter, beating the consensus estimate of N/A by $0.037.
Is Solesence, Inc overvalued?
According to Wall Street analysts Solesence, Inc’s price is currently Overvalued.
Does Solesence, Inc pay dividends?
Solesence, Inc does not currently pay dividends.
What is Solesence, Inc’s EPS estimate?
Solesence, Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solesence, Inc have?
Solesence, Inc has 70,481,940 shares outstanding.
What happened to Solesence, Inc’s price movement after its last earnings report?
Solesence, Inc reported an EPS of $0.037 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -18.95%.
Which hedge fund is a major shareholder of Solesence, Inc?
Currently, no hedge funds are holding shares in SLSN
Solesence Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.93%
12-Months-Change
Fundamentals
Return on Equity
34.76%
Trailing 12-Months
Asset Growth
46.77%
Trailing 12-Months
Company Description
Solesence, Inc
Solesence (SLSN) is a leading innovator in the health and wellness sector, specializing in the development and distribution of advanced skincare solutions. The company focuses on harnessing the power of nature through proprietary formulations that combine botanical extracts with cutting-edge technology. Solesence offers a range of products designed to enhance skin health and beauty, catering to both individual consumers and professional skincare providers.
SLSN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic advancements, including a successful NASDAQ uplisting and new patents. However, significant operational challenges and margin declines due to start-up costs were major concerns.View all SLSN earnings summariesTechnical Analysis
Helen Of Troy
―
Nu Skin
―
Edgewell Personal Care
―
Beauty Health
―
European Wax Center
―
Ownership Overview
74.44% Insiders
1.57% Mutual Funds
0.72% Other Institutional Investors
21.19% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---